FIELD: medicine.
SUBSTANCE: invention is claimed as application of mRNA level of genes 1TGA9, HYAL1 and HYAL2 as markers for diagnostics of epidermoid lung cancer (ELC) and lung adenocarcinoma (LA). Decreased mRNA level of said genes in supposedly affected with cancer human tissue in comparison with its level in healthy tissue serves as diagnostic marker of non-small cell lung cancer.
EFFECT: invention allows to diagnose non-small cell lung cancer of LA and ELC type with high reliability, including the earliest clinical stage of tumour disease.
3 tbl, 7 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR CLEAR CELL RENAL ADENOCARCINOMA AND SET FOR IMPLEMENTATION THEREOF | 2009 |
|
RU2393472C1 |
| METHOD OF DIAGNOSING SQUAMOUS CELL CARCINOMA OF LUNG AND KIT FOR IMPLEMENTATION THEREOF | 2014 |
|
RU2586779C2 |
| DIAGNOSTIC TECHNIQUE FOR NON-SMALL CELL CARCINOMA OF LUNG AND KIT FOR IMPLEMENTATION THEREOF | 2008 |
|
RU2390780C1 |
| METHOD FOR DIAGNOSING BREAST CANCER BY LEVEL OF MRNA TGEβ AND TNFα IN BLOOD PLASMA | 2019 |
|
RU2742209C1 |
| METHOD OF DIAGNOSING NON-SMALL CELL LUNG CANCER AND SET FOR REALISING IT | 2007 |
|
RU2351936C1 |
| METHOD FOR DIAGNOSING BREAST CANCER AND OVARIAN CANCER BY MMP-9 MRNA LEVEL IN BLOOD PLASMA | 2020 |
|
RU2745424C1 |
| METHOD OF DIAGNOSING CLEAR CELL RENAL CELL CARCINOMA AND SET FOR ITS REALISATION | 2012 |
|
RU2545998C2 |
| DIAGNOSTIC TECHNIQUE FOR PAPILLARY CELL RENAL CARCINOMA AND SET FOR IMPLEMENTATION THEREOF | 2014 |
|
RU2605829C2 |
| METHOD OF DIAGNOSING CLEAR CELL RENAL CELL CARCINOMA AND SET FOR ITS REALISATION | 2012 |
|
RU2545995C2 |
| METHOD OF EPIDERMOID LUNG CANCER DIAGNOSTICS AND RELATED SET | 2006 |
|
RU2327162C1 |
